노을
376930KOSDAQ의료용 기기 제조업47.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Noul is a company specializing in the development and sale of on-device AI solutions, 'miLab™', for blood and cancer diagnostics. By automating microscopic pathology processes and integrating AI-based diagnostic technology, miLab™ enables high-precision diagnostics even in environments lacking specialized personnel or infrastructure. The solution currently offers three applications—malaria diagnosis, peripheral blood smear analysis, and cervical cell analysis—and targets the mid-sized diagnostic lab market, where it holds a competitive advantage due to its offline capabilities and cost-effectiveness.
Number of Employees
130people
Average Salary
73.6M KRW
Score Calculation Basis
Detailed Financial Score
Higher than industry avg (caution)
Well below industry avg
1.8x industry avg (risky)
Avg ▲89.2% (2-year basis)
Avg ▼14.7% (2-year basis)
Avg ROE -72.7% (declining, 3yr)
Detailed News Sentiment
- Positive노을, 5대 1 주식병합 결정
노을의 주식병합 결정으로 주가 안정화와 기업 가치 상승 기대.
- Positive노을, 마이랩 디바이스 위탁생산 본격 가동…고수익 체질 전환 및 스.....
노을은 무궁화전자와의 위탁생산 계약으로 고수익 구조 전환과 비용 절감을 동시에 달성하며 긍정적인 시장 반응을 얻고 있다.
- Positive노을, 중남미 최대 진단연맹과 맞손…AI 진단 글로벌 표준화 박차
노을의 AI 진단 기술이 중남미 주요 연맹과의 협약을 통해 글로벌 표준화에 기여하며 긍정적인 시장 반응을 이끌어냄.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -32.80% (strong drop)
Volume flat
Detailed Disclosure
- Neutral주주명부폐쇄기간또는기준일설정2026-06-02
- Neutral주식병합결정2026-06-02
- Neutral주주총회소집결의2026-06-02
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-22
- Neutral기업설명회(IR)개최2026-05-18
